Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations
Gregory M. Laird(Duke Medical Center), Robert F. Siliciano(Howard Hughes Medical Institute), Janet D. Siliciano(Johns Hopkins University), Daniel I. S. Rosenbloom(Columbia University Irving Medical Center), Alison L. Hill(University of Liverpool), C. Korin Bullen(Johns Hopkins University), Alyssa R. Martin(Johns Hopkins University), Christine M. Durand(University of Maryland, Baltimore)
Cited by 403
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia.
|The Journal of Cell Biology|1986|1.6k
Lipidomics reveals a remarkable diversity of lipids in human plasma
|Journal of Lipid Research|2010|1.3k
DNA damage induces phosphorylation of the amino terminus of p53
|Genes & Development|1997|824